Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions 1,5 Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Medication interactions may occur with those on insulin, oral diabetes medications, oral contraceptives, and blood thinners
36 However, PD symptoms are somewhat treatable
Results BPC-157 dose-dependently decreased the number of flinches during phase 1 but did not decrease the number of flinches during phase 2
No other company could have done as much research as did Active White
For patients dealing with stubborn soft-tissue injuries, post-surgical recovery, or chronic inflammation, either peptide is worth discussing with a qualified provider